The Department of Health and Human Services, Office of Inspector General (“OIG”) recently released an unfavorable advisory opinion, OIG Advisory Opinion No. 25‑12 (“AO 25‑12” or the “Opinion”) ...
At the end of 2025, the Office of Inspector General (OIG) of the US Department of Health and Human Services issued Advisory Opinion (AO) 25-11, addressing a biopharmaceutical manufacturer’s proposed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results